Epicenter names five medtech startups to fall ZeroTo510 cohort, including two Tennessee companies
Applicants for the fall 2026 cohort came from eight states, from California to Texas to New York, and of course, Tennessee.
Memphis-based Epicenter has picked five early-stage medtech startups for its latest ZeroTo510 Accelerator cohort, including two Tennessee companies: Provision Surgical of Nashville and ConvertaTek of Memphis.
ZeroTo510 launched in 2012 under the Memphis Bioworks Foundation before moving under Epicenter’s umbrella. More than 50 companies have completed the program, and alumni including SweetBio, Hera Health and Corami have collectively raised over $120 million.
The accelerator runs for 13 weeks and focuses on preparing medtech founders for commercialization. Each company in the cohort gets a $25,000 investment along with training in business planning, FDA regulatory strategy, reimbursement, manufacturing and fundraising.
Olaf Schulz, director of ZeroTo510 at Epicenter, said the program aims to back founders working on healthcare’s biggest unmet needs.
The medtech landscape is evolving faster than ever, and the companies that will define the next decade of healthcare are being built right now. These founders are attacking healthcare’s most pressing unmet needs, and we’re proud to put the full weight of our programming, network and resources behind them.
Meet the Fall 2026 Cohort
Applicants for the fall 2026 cohort came from eight states, from California to Texas to New York. The selected companies:
Provision Surgical (Nashville) — The company’s PAIR Guide system uses AI and augmented reality smart glasses to project a live 3D model of a patient’s anatomy into a surgeon’s field of view during knee replacement surgery, aiming for sub-millimeter accuracy without a surgical robot.
OK2StandUP Inc. (Bedford, Pennsylvania) — The startup combines real-time physiological data with EHR records to flag patients at elevated risk of hospital-acquired pressure injuries, a problem it says costs hospitals nearly $30 billion a year.
ConvertaTek (Memphis) — The company built a modular shoulder implant that lets surgeons switch between anatomic and reverse total shoulder arthroplasty configurations, an option aimed at giving younger patients pain relief without closing off future surgical choices.
Ravan Medical Company (Houston) — Ravan’s PulmVac is a wearable chest drainage device that monitors and manages pneumothorax without requiring bedside wall suction, giving clinicians continuous pressure data to guide treatment.
CuffWay (Columbia, South Carolina) — CuffWay has built an automated cuff-pressure controller for endotracheal and tracheostomy tubes, targeting complications tied to poor airway cuff management that the company says affect nine million intubated patients annually.
The program wraps up with a Demo Day on Dec. 10 at 5:30 p.m. at the FedEx Event Center at Shelby Farms in Memphis, where the companies will pitch to investors and industry leaders.
Like what you've read?
Forward to a friend!